Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Ovarian Neoplasms

  Free Subscription


Articles published in Am J Surg Pathol

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    July 2025
  1. NUMAN TA, Ronnett BM, Haley L, Pallavajjala A, et al
    Clinicopathologic and Molecular Analysis of Malignant Neoplasms With Yolk Sac Tumor Differentiation in Women 40 Years of Age and Older.
    Am J Surg Pathol. 2025;49:686-700.
    PubMed     Abstract available


    May 2025
  2. KEYHANIAN K, Busca A, Howitt B, Hammer P, et al
    Dominant Negative PTEN Alterations in Endometrial Carcinoma Are Associated With Retained Immunohistochemical PTEN Expression.
    Am J Surg Pathol. 2025 May 22. doi: 10.1097/PAS.0000000000002412.
    PubMed     Abstract available


  3. RAY LJ, Young RH, Sabbagh MF, Fisch AS, et al
    Adult Granulosa Cell Tumors of the Ovary With Tubular Differentiation: A Report of 80 Examples of an Underemphasized Feature With Clinicopathologic and Genomic Differences From Other Sex Cord-Stromal Tumors.
    Am J Surg Pathol. 2025 May 6. doi: 10.1097/PAS.0000000000002407.
    PubMed     Abstract available


  4. KARUNADHAS NS, Catherwood M, Stringfellow H, Arora R, et al
    "Early" Clear Cell Proliferations (Clear Cell Carcinoma in Situ) in Ovarian Endometriotic Cysts: Report of a Case Series With Recommendations for Terminology.
    Am J Surg Pathol. 2025 May 6. doi: 10.1097/PAS.0000000000002415.
    PubMed     Abstract available


    April 2025
  5. MA LX, Bennett JA, Tjota MY, Momeni-Boroujeni A, et al
    Comparative Molecular Profiling of "Mixed Endometrioid Adenocarcinoma and Adenosarcoma" of the Uterus and Ovary: A Multi-institutional Series of 14 Cases.
    Am J Surg Pathol. 2025 Apr 7. doi: 10.1097/PAS.0000000000002399.
    PubMed     Abstract available


    March 2025
  6. NEVILLE G, Devins KM, Nucci MR, Watkins JC, et al
    Somatic Malignancies Arising in Ovarian Mature Cystic Teratomas: A Multi-Institutional Study of 40 Cases Highlighting Outcomes and Novel Malignancies.
    Am J Surg Pathol. 2025 Mar 12. doi: 10.1097/PAS.0000000000002384.
    PubMed     Abstract available


    January 2025
  7. PRAT J, D'Angelo E, Espinosa I
    Ovarian Carcinomas: Clinicopathologic and Molecular Features With Comments on 2014 FIGO Staging.
    Am J Surg Pathol. 2025 Jan 14. doi: 10.1097/PAS.0000000000002352.
    PubMed     Abstract available


    September 2024
  8. MORENO-MORENO E, Caniego-Casas T, Carretero-Barrio I, Cortes A, et al
    Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors.
    Am J Surg Pathol. 2024 Sep 13. doi: 10.1097/PAS.0000000000002308.
    PubMed     Abstract available


    August 2024
  9. MAZIBRADA J, Croce S, Foulkes WD, McCluggage WG, et al
    Reply to Letter by Cyrta et al, entitled "Additional considerations on aberrant BRG1 (SMARCA4) expression in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)".
    Am J Surg Pathol. 2024 Aug 21. doi: 10.1097/PAS.0000000000002295.
    PubMed    


  10. CYRTA J, Brillet R, Laas E, Just PA, et al
    Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT).
    Am J Surg Pathol. 2024 Aug 2. doi: 10.1097/PAS.0000000000002296.
    PubMed    


  11. YOON JY, Sharma A, Ligon AH, Ramesh RG, et al
    Genomic Catastrophe (Chromothripsis and Polyploidy) Correlates With Tumor Distribution in Extrauterine High-grade Serous Carcinoma.
    Am J Surg Pathol. 2024;48:1017-1023.
    PubMed     Abstract available


    July 2024
  12. ZHANG X, Devereaux KA, Ryan E, Fei F, et al
    High-grade Anaplastic Transformation of Ovarian Serous Borderline Tumor: A Distinctive Morphology With Abundant Dense Eosinophilic Cytoplasm and Dismal Prognosis.
    Am J Surg Pathol. 2024 Jul 19. doi: 10.1097/PAS.0000000000002294.
    PubMed     Abstract available


  13. DEVINS KM, Young RH
    Embryoid Bodies and Related Proliferations in Ovarian Germ Cell Tumors.
    Am J Surg Pathol. 2024 Jul 4. doi: 10.1097/PAS.0000000000002261.
    PubMed     Abstract available


    May 2024
  14. HAMMER PM, Wang A, Vermij L, Zdravkovic S, et al
    Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous Components.
    Am J Surg Pathol. 2024 May 23. doi: 10.1097/PAS.0000000000002250.
    PubMed     Abstract available


    April 2024
  15. ULBRIGHT TM, Acosta AM
    Ovarian Sex Cord Tumor Harboring FUS::CREM Fusion: An Ovarian Counterpart of Inflammatory and Nested Testicular Sex Cord Tumor.
    Am J Surg Pathol. 2024 Apr 8. doi: 10.1097/PAS.0000000000002221.
    PubMed    


  16. CHIEN YW, Wang Y, Huang P, Lawson BC, et al
    Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions.
    Am J Surg Pathol. 2024;48:475-486.
    PubMed     Abstract available


    March 2024
  17. FADARE O, Fard EV, Bhargava R, Desouki MM, et al
    The Malignant Potential of Ovarian Steroid Cell Tumors Revisited: A Multi-institutional Clinicopathologic Analysis of 115 Cases.
    Am J Surg Pathol. 2024 Mar 21. doi: 10.1097/PAS.0000000000002201.
    PubMed     Abstract available


    February 2024
  18. RUIZ F, Tjendra Y, Millan N, Gomez-Fernandez C, et al
    Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
    Am J Surg Pathol. 2024 Feb 15. doi: 10.1097/PAS.0000000000002193.
    PubMed     Abstract available


    January 2024
  19. SHIBAYAMA T, Hayashi A, Nagahama K, Hibiya T, et al
    Ovarian Sex Cord Tumor Harboring FUS::CREM Fusion: An Ovarian Counterpart of Inflammatory and Nested Testicular Sex Cord Tumor?
    Am J Surg Pathol. 2024 Jan 15. doi: 10.1097/PAS.0000000000002180.
    PubMed    


    December 2023
  20. KEYHANIAN K, Han L, Howitt BE, Longacre T, et al
    Specific Pathology Features Enrich Selection of Endometrial Carcinomas for POLE Testing.
    Am J Surg Pathol. 2023 Dec 8. doi: 10.1097/PAS.0000000000002165.
    PubMed     Abstract available


    November 2023
  21. YANG B, Chour W, Salazar CG, Zamiara P, et al
    Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
    Am J Surg Pathol. 2023 Nov 10. doi: 10.1097/PAS.0000000000002149.
    PubMed     Abstract available


    October 2023
  22. MENDOZA RP, Wang P, Smith HL, Fitzpatrick CA, et al
    Clinicopathologic Analysis and Molecular Profiling of Ovarian Steroid Cell Tumors.
    Am J Surg Pathol. 2023 Oct 5. doi: 10.1097/PAS.0000000000002124.
    PubMed     Abstract available


    September 2023
  23. TOMONOBE H, Ohishi Y, Hachisuga K, Yahata H, et al
    High-grade Serous Carcinoma can Show Squamoid Morphology Mimicking True Squamous Differentiation.
    Am J Surg Pathol. 2023;47:967-976.
    PubMed     Abstract available


    July 2023
  24. PORS J, Weiel JJ, Ryan E, Longacre TA, et al
    The Evolving Spectrum of Endometrial Glandular Proliferations With Corded and Hyalinized Features.
    Am J Surg Pathol. 2023 Jul 27. doi: 10.1097/PAS.0000000000002078.
    PubMed     Abstract available


  25. DEVINS KM, Young RH
    Sclerosis in Sex Cord-Stromal Tumors Other Than the Sclerosing Stromal Tumor: A Report of 70 Cases.
    Am J Surg Pathol. 2023;47:774-784.
    PubMed     Abstract available


    June 2023
  26. EUSCHER ED, Marques-Piubelli ML, Ramalingam P, Wistuba I, et al
    Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
    Am J Surg Pathol. 2023;47:635-648.
    PubMed     Abstract available


    May 2023
  27. BI R, Yao Q, Ji G, Bai Q, et al
    Uterine Tumor Resembling Ovarian Sex Cord Tumors: 23 Cases Indicating Molecular Heterogeneity With Variable Biological Behavior.
    Am J Surg Pathol. 2023 May 3. doi: 10.1097/PAS.0000000000002046.
    PubMed     Abstract available


  28. CHUI MH, Ellenson LH
    Mixed Ovarian Neoplasms With Gastrointestinal-type Mucinous and Mullerian Epithelial Components: A Rare Group of Tumors Demonstrating the Phenotypic Plasticity of the Mullerian Epithelial Cell.
    Am J Surg Pathol. 2023 May 1. doi: 10.1097/PAS.0000000000002045.
    PubMed     Abstract available


    April 2023
  29. MCCLUGGAGE WG, Rivera B, Chong AS, Clarke BA, et al
    Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
    Am J Surg Pathol. 2023;47:490-496.
    PubMed     Abstract available


    March 2023
  30. JOEHLIN-PRICE AS, Komforti MK, Ladwig NR, Devine P, et al
    HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy.
    Am J Surg Pathol. 2023 Mar 20. doi: 10.1097/PAS.0000000000002030.
    PubMed     Abstract available


  31. AGUILAR M, Chen H, Sahoo SS, Zheng W, et al
    beta-catenin, Pax2, and Pten Panel Identifies Precancers Among Histologically Subdiagnostic Endometrial Lesions.
    Am J Surg Pathol. 2023 Mar 20. doi: 10.1097/PAS.0000000000002034.
    PubMed     Abstract available


  32. MENDOZA RP, Wang P, Schulte JJ, Tjota MY, et al
    Endometrial Carcinomas With Subclonal Loss of Mismatch Repair Proteins: A Clinicopathologic and Genomic Study.
    Am J Surg Pathol. 2023 Mar 3. doi: 10.1097/PAS.0000000000002031.
    PubMed     Abstract available


    February 2023
  33. WIEDENHOEFER R, Schmoeckel E, Grube M, Sulyok M, et al
    L1-CAM in Mucinous Ovarian Carcinomas and Borderline Tumors: Impact on Tumor Recurrence and Potential Role in Tumor Progression.
    Am J Surg Pathol. 2023 Feb 28. doi: 10.1097/PAS.0000000000002027.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.